Pathogenic mutations in PAX3 disrupt its ability to regulate cell proliferation, differentiation, migration, and survival, particularly in cells derived from neural crest cells (NCCs), leading to the onset of WS1 and WS3 symptoms (Matsunaga et al., 2013). The gene discussed is PAX3; the disease is Waardenburg syndrome type 1.